Royalty Pharma plc Due to Related Parties, Noncurrent
Royalty Pharma plc (RPRX) had Due to Related Parties, Noncurrent of $98.58 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Notes
us-gaap:DueToRelatedPartiesNoncurrent · last filed 2023-05-09
- 2023-03-31: Due to Related Parties, Noncurrent $98.58M.
- 2022-12-31: Due to Related Parties, Noncurrent $94.80M.
- 2022-09-30: Due to Related Parties, Noncurrent $105.73M.
- 2022-06-30: Due to Related Parties, Noncurrent $115.99M.
| Period end | Due to Related Parties, Noncurrent |
|---|---|
| 2023-03-31 | $98.58M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $94.80M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $105.73M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $115.99M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $116.01M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $107.93M 10-K · filed 2023-02-15 |
| 2021-09-30 | $119.14M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $117.38M 10-Q · filed 2021-08-11 |
| 2020-12-31 | $126.37M 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |